Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
33.43
-2.98 (-8.18%)
At close: Apr 1, 2025, 4:00 PM
35.11
+1.68 (5.02%)
After-hours: Apr 1, 2025, 7:59 PM EDT

Monopar Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-15.59-8.4-10.52-9.1-6.3
Upgrade
Stock-Based Compensation
1.141.91.641.471.32
Upgrade
Other Operating Activities
4.55----0.12
Upgrade
Change in Accounts Payable
0.51-1.331.480.40.45
Upgrade
Change in Other Net Operating Assets
2.98-0.020.17-0.09-0
Upgrade
Operating Cash Flow
-6.4-7.86-7.23-7.32-4.66
Upgrade
Investment in Securities
-14.344.93-4.92--
Upgrade
Investing Cash Flow
-14.344.93-4.92--
Upgrade
Long-Term Debt Issued
----0.12
Upgrade
Net Debt Issued (Repaid)
----0.12
Upgrade
Issuance of Common Stock
59.42.070.1111.288.43
Upgrade
Repurchase of Common Stock
-0.1-0.05-0.08-0.06-
Upgrade
Other Financing Activities
----0.34-0.37
Upgrade
Financing Cash Flow
59.292.030.0310.888.18
Upgrade
Foreign Exchange Rate Adjustments
0-0.02-000
Upgrade
Net Cash Flow
38.55-0.92-12.123.573.52
Upgrade
Cash Income Tax Paid
-----0.01
Upgrade
Levered Free Cash Flow
-6.62-5.01-3.22-3.99-2.34
Upgrade
Unlevered Free Cash Flow
-6.62-5.01-3.22-3.99-2.34
Upgrade
Change in Net Working Capital
-3.481.39-1.72-0.25-0.41
Upgrade
Updated Nov 8, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q